Precigen (PGEN) Current Assets (2012 - 2026)
Precigen (PGEN) reported Current Assets of $101.7 million for Q1 2026, up 20.18% year-over-year from $84.6 million in Q1 2025, and down 11.77% quarter-over-quarter from $115.2 million in Q4 2025.
Precigen (PGEN) Current Assets (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Current Assets data on file, last reported at $101.7 million in Q1 2026.
- Current Assets for Q1 2026 came in at $101.7 million, up 20.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $101.7 million (up 20.18% YoY), and the FY2025 annual result was $115.2 million, up 12.52% from the prior year.
- Current Assets retreated to $101.7 million in Q1 2026 per PGEN's latest filing, from $115.2 million in the prior quarter.
- Over five years, Current Assets peaked at $164.6 million in Q2 2022 and troughed at $23.7 million in Q2 2024.
- A 5-year average of $100.6 million and a median of $102.4 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets slumped 77.55% in 2024, then jumped 275.5% in 2025.
- A 5-year view of Current Assets shows it stood at $118.2 million in 2022, then slumped by 41.81% to $68.8 million in 2023, then surged by 48.95% to $102.4 million in 2024, then increased by 12.52% to $115.2 million in 2025, then slipped by 11.77% to $101.7 million in 2026.
- Business Quant data shows PGEN's Current Assets at $101.7 million in Q1 2026, $115.2 million in Q4 2025, and $129.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 600.85 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 101.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.67 Mn |
| Dec 31, 2025 | 115.24 Mn |
| Sep 30, 2025 | 129.60 Mn |
| Jun 30, 2025 | 62.76 Mn |
| Mar 31, 2025 | 84.60 Mn |
| Dec 31, 2024 | 102.41 Mn |
| Sep 30, 2024 | 34.51 Mn |
| Jun 30, 2024 | 23.72 Mn |
| Mar 31, 2024 | 49.55 Mn |
| Dec 31, 2023 | 68.76 Mn |
| Sep 30, 2023 | 92.99 Mn |
| Jun 30, 2023 | 105.63 Mn |
| Mar 31, 2023 | 137.74 Mn |
| Dec 31, 2022 | 118.16 Mn |
| Sep 30, 2022 | 162.81 Mn |
| Jun 30, 2022 | 164.62 Mn |
| Mar 31, 2022 | 154.94 Mn |
| Dec 31, 2021 | 156.63 Mn |
| Sep 30, 2021 | 153.09 Mn |
| Jun 30, 2021 | 156.69 Mn |